Our study shows that METTL3 expression is increased in mycosis fungoides compared with the inflammatory disease lichen planus, revealing that elevated METTL3 expression may act as an oncogenic driver in CTCL progression. Here, METTL3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.